ArticleAbdominal radiology (New York)2025
Using interpretable rule-learning artificial intelligence to optimally differentiate adrenal pheochromocytomas from adenomas with CT radiomics.
Article in Abdominal radiology (New York), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The application of artificial intelligence in adrenal imaging: current state of knowledge, challenges, and future directions.Endocrine connections · 2026Article
- AI-enabled precision evaluation of adrenal masses: radiomics, deep learning, and explainable imaging biomarkers.Frontiers in endocrinology · 2026Review
- An interpretable machine learning framework using multi-phase computed tomography for differentiation of adrenal lipid-poor adenomas and pheochromocytomas.Frontiers in artificial intelligence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo identify interpretable CT-based radiomics features that can differentiate adrenal pheochromocytomas from adenomas.
methodsAn institutional database was used to identify patients with pathologically proven adrenal pheochromocytomas 5/1/05-5/1/23. To be included, patients needed to have a contrast-enhanced abdominal CT with an adrenal mass within 12 months of pathology (n = 95). For comparison, 57 adenomas were identified from a set of consecutive CT examinations. The final dataset included 152 adrenal masses (95 pheochromocytomas; 57 adenomas) with 121 used in the development set and 31 in the test set. Following confirmation of accurate automated segmentation, 463 radiomic features were evaluated and used to create an interpretable artificial intelligence (AI) rule-learning model. Model performance was reported using F1 score.
resultsThe study included 146 patients (age 59 years +/- 21; 89 females). A three-feature rule, High Gray Level Zone Emphasis > 184, Roundness > 0.35, and Boundary Low Gray Level Emphasis < 0.021 produced an F1 score of 0.97 on the train set (95% confidence interval [CI]: 0.94, 0.99) and 0.96 on the test set (95% CI: 0.89, 1.00). The rule-learning model determined that the rule most predictive of pheochromocytoma was Maximum Pixel Attenuation > 125 HU resulting in an F1 score of 0.89 (95% CI: 0.83, 0.94) on the training set and 0.93 (95% CI: 0.83, 0.99) on the test set.
conclusionA rule-learning AI model identified the smallest optimal set of interpretable CT radiomics features, sufficient to achieve 96% accuracy in differentiating adrenal pheochromocytomas from adenomas on contrast enhanced CT.
Indexed as
Identifiers
40137949What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.